Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 0.0033113 | uM | 7 | 625.00 | 270.29 | 738.00 | 712.50 | 1.0358 | 1.0509 |
| BT-20 | 17-AAG | 0.31623 | uM | 7 | 625.00 | 270.29 | 309.00 | 712.50 | 0.4337 | 0.1004 |
| BT-20 | 17-AAG | 0.01 | uM | 7 | 625.00 | 270.29 | 544.00 | 712.50 | 0.7635 | 0.6490 |
| BT-20 | Lapatinib | 1 | uM | 7 | 625.00 | 270.29 | 814.00 | 712.50 | 1.1425 | 1.1998 |
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 625.00 | 270.29 | 669.00 | 712.50 | 0.9390 | 0.9119 |
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 625.00 | 270.29 | 774.00 | 712.50 | 1.0863 | 1.1220 |
| BT-20 | Lapatinib | 0.31623 | uM | 7 | 625.00 | 270.29 | 795.00 | 712.50 | 1.1158 | 1.1630 |
| BT-20 | Erlotinib | 10 | uM | 7 | 625.00 | 270.29 | 520.00 | 712.50 | 0.7298 | 0.5967 |
| BT-20 | Erlotinib | 19.9526 | uM | 7 | 625.00 | 270.29 | 766.00 | 712.50 | 1.0751 | 1.1063 |
| BT-20 | 17-AAG | 0.0033113 | uM | 7 | 625.00 | 270.29 | 509.00 | 712.50 | 0.7144 | 0.5724 |
| BT-20 | Lapatinib | 10 | uM | 7 | 625.00 | 270.29 | 297.00 | 712.50 | 0.4168 | 0.0697 |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 669.00 | 712.50 | 0.9390 | 0.9119 | |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 2.00 | 712.50 | 0.0028 | -0.9701 | |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 3.00 | 1814.50 | 0.0017 | -0.9592 | |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 1697.00 | 1814.50 | 0.9352 | 0.9203 | |
| BT-20 | Linsitinib | 0.01 | uM | 7 | 1250.00 | 580.08 | 1867.00 | 1814.50 | 1.0289 | 1.0350 |
| BT-20 | Linsitinib | 0.031623 | uM | 7 | 1250.00 | 580.08 | 1689.00 | 1814.50 | 0.9308 | 0.9147 |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 1849.00 | 1814.50 | 1.0190 | 1.0230 | |
| BT-20 | 17-AAG | 1 | uM | 7 | 1250.00 | 580.08 | 614.00 | 1814.50 | 0.3384 | 0.0351 |
| BT-20 | Linsitinib | 10 | uM | 7 | 1250.00 | 580.08 | 1402.00 | 1814.50 | 0.7727 | 0.7098 |
| BT-20 | 17-AAG | 0.1 | uM | 7 | 1250.00 | 580.08 | 677.00 | 1814.50 | 0.3731 | 0.0985 |
| BT-20 | Lapatinib | 0.01 | uM | 7 | 1250.00 | 580.08 | 1948.00 | 1814.50 | 1.0736 | 1.0882 |
| BT-20 | 17-AAG | 0.031623 | uM | 7 | 1250.00 | 580.08 | 716.00 | 1814.50 | 0.3946 | 0.1365 |
| BT-20 | Lapatinib | 0.1 | uM | 7 | 1250.00 | 580.08 | 2061.00 | 1814.50 | 1.1359 | 1.1610 |
| BT-20 | Lapatinib | 0.031623 | uM | 7 | 1250.00 | 580.08 | 1777.00 | 1814.50 | 0.9793 | 0.9748 |